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 Nager syndrome, or acrofacial dysostosis type 1 
(AFD1; OMIM #154400), is a well-known pleiotropic 
malformation syndrome defined by the association of hy-
poplasia of first and second branchial arches derivatives 
(i.e. downslanting palpebral fissures, malar hypoplasia/
flattening, malformed ears, and micrognathia) and ap-
pendicular anomalies with variable involvement of the 
radial/axial ray. The former feature may be so severe in 
specific cases that it partly overlaps with otocephaly, 
which, in turn, may be distinguished from AFD1 by total 
agenesis of the mandible (i.e. agnathia) and midline fu-
sion of the external ears below the maxillae. Appendicular 
involvement, usually limited to the upper limbs, is con-
sidered the hallmark of AFD1 and allows differentiation 
from other AFDs, such as Miller syndrome [Halal et al., 
1983; Opitz, 1987]. For decades, the molecular basis of 
AFD1 remained unknown, with most cases occurring 
sporadically and rarely clustering in families and there-
fore being compatible with both autosomal dominant 
and recessive transmission [Chemke et al., 1988; Hall, 
1989; Aylsworth et al., 1991; McDonald and Gorski, 1993; 
Kennedy and Teebi, 2004]. Bernier et al. [2012] identified 
18 different heterozygous mutations in the  SF3B4 gene in 
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 Abstract 
 Nager syndrome, or acrofacial dysostosis type 1 (AFD1), is a 
rare multiple malformation syndrome characterized by hy-
poplasia of first and second branchial arches derivatives and 
appendicular anomalies with variable involvement of the ra-
dial/axial ray. In 2012, AFD1 has been associated with domi-
nant mutations in  SF3B4 . We report a 22-week-old fetus with 
AFD1 associated with diaphragmatic hernia due to a previ-
ously unreported  SF3B4 mutation (c.35–2A>G). Defective di-
aphragmatic development is a rare manifestation in AFD1 as 
it is described in only 2 previous cases, with molecular con-
firmation in 1 of them. Our molecular finding adds a novel 
pathogenic splicing variant to the  SF3B4  mutational spec-
trum and contributes to defining its prenatal/fetal pheno-
type.  © 2014 S. Karger AG, Basel 
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20 families from a total of 35 pedigrees with a clinical di-
agnosis of AFD1. Sixteen additional families with mo-
lecularly confirmed AFD1 were subsequently reported 
[Czeschik et al., 2013; Petit et al., 2013]. In all but 4 cases, 
the diagnosis was established after birth. Here, we report 
a 22-week-old fetus with AFD1 and diaphragmatic hernia 
carrying a novel  SF3B4 mutation.
 Case Report 
 The fetus was the second child of a 33-year-old healthy woman 
and her unrelated 37-year-old husband. The pregnancy progressed 
uneventful, without exposure to any known teratogen. Standard 
second trimester ultrasound screening, performed at the 21st week 
of gestation, revealed multiple malformations, comprising intra-
thoracic visualization of the gastric bubble and a severe reduction 
defect of the upper limbs. Two days later, a further ultrasound ex-
amination better characterized the observed defects as diaphrag-
matic hernia with thoracic translocation of the stomach and hypo-
plasia of the left lung and marked shortening of the upper limbs 
with predominant involvement of the radial ray. Hypoplasia of the 
maxillae and mandibula was also noted. Amniocentesis was not 
performed, and the couple chose for termination of pregnancy at 
22 weeks of gestation. External examination was consistent with a 
female fetus showing apparent hypertelorism, downslanting pal-
pebral fissures with lateral flares of the eyebrows, hypoplasia of the 
middle face, and severe micrognathia. The ears appeared small and 
slightly low-set and lacked an external auditory canal. The upper 
limbs were hypoplastic with marked shortening of the forearms 
and radial clubhands. Both hands were 4-fingered, and the first 
radial fingers showed complete distal duplication. Evisceration 
confirmed left diaphragmatic agenesis with intra-thoracic local-
ization of the stomach and revealed agenesis of the uterus. Fetal 
radiographs showed marked retro-micrognathia, reduced volume 
of both maxillary bones, aplasia of both radii and right ulna, severe 
hypoplasia of the left ulna, oligodactyly with 4 metacarpals in both 
hands, broad proximal phalanx of the first fingers, which were dis-
tally duplicated with rudimentary middle phalanges, and double 
distal phalanges. A clinical diagnosis of Nager syndrome/AFD1 
was established ( fig. 1 a–k).
 Material and Methods 
 Genomic DNA was extracted from the aborted fetus and pe-
ripheral blood of both parents by standard methods. Fetal DNA 
was analyzed for  SF3B4 mutations by Sanger sequencing. The en-
tire  SF3B4 coding region and splicing junctions were amplified in 
7 PCR fragments using the following primer pairs: F: 5 Ԣ -TCTTC-
GCCCCGGAAGT-3 Ԣ and R: 5 Ԣ -CCCACCCCTGCAGAGAC-3 Ԣ 
(exon 1), F: 5 Ԣ -TGTTTCCATCACTTCCTTCCTT-3 Ԣ and R: 
5 Ԣ -TGAATACTGCTGGGACCCT-3 Ԣ (exon 2), F: 5 Ԣ -TCAGTT-
TATTTCTGGAACCATTCTT-3 Ԣ and R: 5 Ԣ -ACAGAGGTACT-
GCCCATTCA-3 Ԣ (exon 3), F: 5 Ԣ -GCCTTTGGGGTCATCTTA-
CA-3 Ԣ and R: 5 Ԣ -CCTCAGTCCTCTTCCCATCA-3 Ԣ (exon 3), F: 
5 Ԣ -AGGCCAGATCAGGACAGG-3 Ԣ and R: 5 Ԣ -CTGTTGAGGAA-
CAAAGGGCA-3 Ԣ (exon 4), F: 5 Ԣ -GCTGTTCTTGAACTCCT-
GGG-3 Ԣ and R: 5 Ԣ -AAGTTAGTAAGGGCACGGGA-3 Ԣ (exon 5), 
and F: 5 Ԣ -TCTAGCCACCTCCCTCATCT-3 Ԣ and R: 5 Ԣ -GGAT-
TAGTACCTTTGCCCCA-3 Ԣ (exon 6). Primers were designed us-
ing the NCBI/Primer-BLAST software [Ye et al., 2012], and the 
pairs with partial or total identity with the retro- SF3B4 pseudogene 
(chr14: 67665808–67666576) were excluded. PCR reactions were 
carried out under standard conditions. Direct sequencing was per-
formed using a BigDye Terminator v1.1 Cycle Sequencing Kit (Life 
Technologies, Foster City, Calif., USA) and the standard protocol. 
Electropherograms were compared with the  SF3B4 mRNA refer-
ence sequence (NM_005850).
 Results and Discussion 
 A novel heterozygous splicing variant c.35–2A>G was 
identified in the fetus and confirmed in 2 separately
extracted samples of DNA ( fig.  1 l). This nucleotide 
change was found neither in the parents’ DNA, indicat-
ing a de novo nature, nor in 200 control chromosomes 
from unaffected, ethnicity-matched individuals. Non-
paternity was excluded by microsatellite analysis. The 
dbSNP (www.ncbi.nlm.nih.gov/SNP/) and 1000 Genomes
(www.1000genomes.org) databases were searched for 
the same variant with negative results. In silico predic-
tion using the online NNSPLICE 0.9 version web inter-
face (www.fruitfly.org/seq_tools/splice.html) showed 
that the identified c.35–2A>G variant abolishes the ca-
nonical acceptor splice site of  SF3B4 exon 2 while it cre-
ates a new acceptor spice site a single nucleotide up-
stream. This variation was then assumed to retain the last 
nucleotide of  SF3B4 intron 1 into the exon 2 coding se-
quence, resulting in a frameshift with the creation of a 
premature stop codon at residue 22 of the coded protein. 
The presence of the same nucleotide change in the retro-
 SF3B4 pseudogene (located at chr14: 67665811G) point-
ed out gene conversion as a potential mutagenic mecha-
nism for the identified mutation, but no further study 
was carried out in order to test this hypothesis.
 To date, a total of 46 AFD1 patients from 36 pedigrees 
(8 familial, 28 sporadic) with a mutation in  SF3B4 have 
been identified [Bernier et al., 2012; Czeschik et al., 2013; 
Petit et al., 2013].Thirty distinct  SF3B4 mutations are de-
scribed, including 20 frameshift, 6 nonsense, 2 splice, and 
2 initiator codon nucleotide changes. All mutations are 
predicted to cause loss-of-function, although any func-
tional study or the description of AFD1 patients with a 
complete gene deletion have not been published to date. 
Our molecular finding is in line with previous observa-
tions and adds a novel pathogenic splicing variant (c.35–
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 Fig. 1.  a Whole-body picture of the fetus showing typical appen-
dicular and craniofacial features.  b–e Comparison of the clinical 
( b right lateral view,  c frontal view) and radiographic ( d right lat-
eral view,  e frontal view) presentation of the craniofacial anoma-
lies.  f–i Comparison of the clinical ( f left hand,  g right hand) and 
radiographic ( h left hand,  i right hand) presentation of the hand 
anomalies.  j Cranial dislocation of the gut through a large defect of 
the left diaphragm.  k Partial evisceration showing complete agen-
esis of the left hemi-diaphragm.  l Direct sequencing electrophero-
gram of the acceptor splicing junction of SF3B4 exon 2, showing 
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AFD1. In consideration of the severity of the observed 
phenotype, our findings permitted an accurate genetic 
counseling for the couple and, subsequently, the oppor-
tunity of offering early prenatal diagnosis.
 Genotype-phenotype correlations can not be estab-
lished with certainty in  SF3B4 mutations [Petit et al., 
2013]. Among patients with a clinical diagnosis of AFD1, 
preliminary comparisons suggest a significant increased 
rate of hearing loss, cleft palate, midface hypoplasia, and 
thumb aplasia (as opposed to thumb hypoplasia of tripha-
langeal thumb) in subjects carrying a  SF3B4  alteration, 
compared to those not displaying any mutation [Cze-
schik et al., 2013]. Our patient showed full-blown charac-
teristics of AFD1, but circumstances did not permit a bet-
ter characterization of the phenotype, particularly con-
cerning subtle or functional features that are not easily 
testable in fetuses. In addition to the facial phenotype, the 
diagnosis was supported by the evocative hand involve-
ment with pre-axial oligodactyly with 4 three-phalangeal, 
not opposable fingers and distal duplication of the first 
one. Such a recognizable pattern, well documented in at 
least 2 additional AFD1 patients with mutations in  SF3B4 
[Czeschik et al., 2013; Petit et al., 2013], supports the con-
cept that the encoded protein is not only involved in ubiq-
uitous mechanisms of mRNA splicing but may specifi-
cally affect bone morphogenesis with different mecha-
nisms, such as inhibition of BMP-mediated osteochondral 
cell differentiation [Watanabe et al., 2007]. However, spe-
cific influence of  SF3B4 perturbations on limb patterning 
is likely an inconstant mechanism in AFD1, as many pa-
tients do not display the recognizable digital phenotype. 
In turn, it is presumed that limb anomalies arise in AFD1 
non-specifically, secondary to abnormalities in cell divi-
sion, as illustrated, for example, by the mouse oligosyn-
dactylism mutants [Pravtcheva and Wise, 2001].
 Our patient presented lethal left diaphragmatic her-
nia. Defective diaphragmatic development is a rare oc-
currence in AFD1, as it is reported in only 2 previously 
reported cases, with molecular confirmation in 1 of 
them [Czeschik et al., 2013; Petit et al., 2013]. The 2 mu-
tations, including ours, reported in AFD1 patients with 
diaphragmatic hernia do not suggest any consistent 
genotype-phenotype correlation. However, the repeat-
ed observation of diaphragmatic hernia in AFD1 seems 
to be an association and might further expand the spec-
trum of non-causal morphogenetic consequences of 
 SF3B4  perturbations. The mechanisms leading to such 
a low-frequency association remain unknown and may 
include a variable genetic background, environmental 
factors, and stochastic events. 
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